Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,464
Recruiting: 821
Ph III recruiting: 96
Growth YoY: +6%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 251–300 of 848 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04188847	First-line Chemotherapy for Recurrent Cervical Cancer	completed	Phase 2	37	Lei LiOTHER	1	Mar 15, 2022	clinicaltrials
NCT04188860	Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy	completed	Phase 2	34	Lei LiOTHER	1	Mar 15, 2022	clinicaltrials
NCT02889900